Endometrial cancer is considered as one of the most frequent gynecological malignancies. In recent years, its frequency has grown globally. At stage I, endometrial cancer is commonly identified meaning that the tumor is limited only to the uterus. The standard surgery for those patients is total abdominal hysterectomy.
Over time, other several therapeutic approaches have been used in inoperable women, including hysteroscopic endometrial resection.
The present research objective was to determine the efficacy of hysteroscopic endometrial resection as a conservative treatment of the early-stage cases of endometrial cancer in high surgical risk patients.
This study was performed on a group of 15 diagnosed patients of early endometrial cancer FIGO stage IA. The participants were attending at El Shatby maternity hospital from January 2021 to December 2022 in order to assess the efficacy of hystroscopic endometrial resection on the disease's outcome.
AIM:
This study's aim was to determine the efficacy of hysteroscopic endometrial resection as a conservative treatment of early stage cases of the endometrial cancer in females facing a high surgical risk.